Clinical Trials
16
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
A Multicenter, International, Prospective and Retrospective, Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech Paravalvular Leak Device (PLD) in Patients With Mitral or Aortic Paravalvular Leaks
- Conditions
- Paravalvular Leak Device (PLD)
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Occlutech International AB
- Target Recruit Count
- 200
- Registration Number
- NCT07037446
- Locations
- 🇹🇷
Kocaeli Üniversitesi Hastanesi, Kocaeli, Turkey
Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases
- Conditions
- Muscular Ventricular Septal Defect
- First Posted Date
- 2022-04-15
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Occlutech International AB
- Target Recruit Count
- 100
- Registration Number
- NCT05329350
- Locations
- 🇹🇷
Gaziantep Unıversıty Hospital, Gaziantep, Şehitkamil, Turkey
PMCF Study to Evaluate Efficacy, Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects
- Conditions
- Patent Ductus Arteriosus
- First Posted Date
- 2022-03-03
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Occlutech International AB
- Target Recruit Count
- 255
- Registration Number
- NCT05264753
- Locations
- 🇮🇹
Ospedale Pediatrico Bambin Gesù, Roma, Italy
🇵🇰Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
🇹🇳Military Hospital, Tunis, Tunisia
ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices
- Conditions
- Heart Diseases
- First Posted Date
- 2021-12-30
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Occlutech International AB
- Target Recruit Count
- 685
- Registration Number
- NCT05174442
- Locations
- 🇩🇪
Klinikum der Universität München, München, Germany
🇹🇷İzmir Şehir Hastanesi, İzmir, Bayraklı, Turkey
🇹🇷İstanbul Mehmet Akif Ersoy Göğüs Kalp ve Damar Cerrahisi Eğitim ve Araştırma Hastanesi, İstanbul, Küçükçekmece, Turkey
Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study
- Conditions
- Heart Failure With Preserved Ejection Fraction (HFpEF)Heart Failure With Reduced Ejection Fraction (HFrEF)
- First Posted Date
- 2021-11-29
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Occlutech International AB
- Target Recruit Count
- 15
- Registration Number
- NCT05136820
- Locations
- 🇺🇸
Arizona Heart Rhythm Center, Phoenix, Arizona, United States
🇺🇸North Shore Northwell University Hospital Lenox Hill, New York, New York, United States
- Prev
- 1
- 2
- 3
- Next